M. Vignali

ORCID: 0000-0002-9806-3741 · 115 papers in corpus
observational 2003
Molecular human reproduction ·doi:10.1093/molehr/gag002

Endometriosis is a gynaecological disease with a certain genetic background, but the locations of possible genomic aberrations are still poorly clarified. Intercellular adhesion molecule-1 (ICAM-1), which is a surface glycoprotein that prom…

review 2003
Current opinion in obstetrics & gynecology ·doi:10.1097/01.gco.0000084247.09900.4f

PURPOSE OF REVIEW: This review analyzes the literature on ovarian endometrioma, examining the controversies on pathogenesis, malignant transformation and surgical therapy. RECENT FINDINGS: Recent literature reflects the necessity of clearl…

2003
·doi:10.1016/s1074-3804(03)80036-1
review 2003
·doi:10.1097/00001703-200308000-00005

Purpose of review This review analyzes the literature on ovarian endometrioma, examining the controversies on pathogenesis, malignant transformation and surgical therapy. Recent findings Recent literature reflects the necessity of clearly d…

2002
·doi:10.1016/s0015-0282(01)03072-2
2002
·doi:10.1016/s0015-0282(01)03016-3
rct 2002
·doi:10.1097/00006254-200205000-00018

Symptomatic women with stage III to IV endometriosis today are most often managed by conservative laparoscopic surgery, but recurrences continue to occur. Roughly one in five patients will have further disease within 5 years after complete …

2002
·doi:10.1016/s0015-0282(02)02983-7
2002
·doi:10.1016/s0015-0282(01)03169-7
lab-animal 2001
Human Reproduction ·doi:10.1093/humrep/16.6.1076

Follicular fluid from women with endometriosis has been shown to induce a higher endometrial cell proliferation than that derived from women without the disease. To elucidate this issue further, the aims of the present study were to compare…

other 2001
Fertility and sterility ·doi:10.1016/s0015-0282(01)01884-2
lab-animal 2001
Acta obstetricia et gynecologica Scandinavica ·doi:10.1034/j.1600-0412.2001.080003200.x

BACKGROUND: It is still unclear whether the immunologic perturbation observed in women with endometriosis represents an intrinsic defect of the immune system or it is consequent to the presence of endometrium in ectopic sites. The present s…

rct 2001
Human Reproduction ·doi:10.1093/humrep/16.11.2399

BACKGROUND: In order to decrease endometriosis recurrence after surgical therapy, it has been proposed to use a post-surgical oestrogen-lowering medical treatment. Results from previous trials on this topic are contradictory. METHODS: A to…

lab-animal 2001
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1034/j.1600-0897.2001.d01-22.x

PROBLEM: It has been suggested that specific mechanisms commonly used by different cellular systems to evade immunologic recognition are involved in the development of endometriosis. To gain insight into this aspect, we looked at the relati…

lab-animal 2001
Fertility and sterility ·doi:10.1016/s0015-0282(00)01659-9

OBJECTIVE: To test the possibility of using transgenic knockout mice in the study of endometriosis and to investigate specific immunologic aspects of the disease. DESIGN: Experimental blinded study. SETTING: Academic research center. ANI…

other 2000
Obstetrics and gynecology ·doi:10.1016/s0029-7844(99)00465-2

OBJECTIVE: To relate endometrial release of the soluble form of intercellular adhesion molecule 1 with extent of endometriosis. METHODS: Samples of endometrium were collected from 23 women with endometriosis. Soluble intercellular adhesion…

lab-animal 2000
Molecular and cellular endocrinology ·doi:10.1016/s0303-7207(99)00199-9

The present study was conducted to investigate whether GnRH-receptor (GnRH-R) gene is expressed in endometriosis ovarian implants and whether a GnRH-analogue (GnRH-a) may exert an effect on endometriosis cell proliferation in vitro. The pre…

rct 1999
Human Reproduction ·doi:10.1093/humrep/14.5.1335

The effect of treatment with danazol was evaluated with respect to expectant management after laparoscopic conservative surgery. All patients conservatively operated at laparoscopy for stage III-IV endometriosis from July 1994 to October 19…

lab-animal 1999
Human Reproduction ·doi:10.1093/humrep/14.12.2944

Immune dysfunctions in endometriosis are widely documented but the effectiveness of immunotherapies for the management of the disease is still debated. Progress in this field has also been limited by the lack of an appropriate animal model …

review 1999
Human Reproduction Update ·doi:10.1093/humupd/5.1.40

The observation that natural killer (NK) cell activity is abnormally low in endometriosis patients and abnormally high in women with otherwise unexplained recurrent spontaneous abortion represents, at present, an intriguing curiosity. There…

nonrandomized-trial 1999
The Journal of the American Association of Gynecologic Laparoscopists ·doi:10.1016/s1074-3804(99)80041-3

STUDY OBJECTIVE: To evaluate the efficacy of conservative laparoscopic surgery in a series of patients with stage III-IV endometriosis. DESIGN: Prospective study (Canadian Task Force classification II-1). SETTING: University-affiliated ho…

other 1998
Molecular human reproduction ·doi:10.1093/molehr/4.12.1150

The relationship between the immune and the endometrial systems has been recently suggested to be critical to the development of endometriosis. We previously showed that one of the molecules involved in the complex events that allow this in…

other 1998
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.83.3.4612

An alteration of immune recognition and killing of misplaced endometrial cells, refluxed with menstrual debris in ectopic sites, has been claimed to be responsible for the initiation and progression of endometriosis. In particular, current …

review 1998
Gynecologic and obstetric investigation ·doi:10.1159/000052845

The mechanisms leading to the occurrence and progression of endometriosis are far from being completely understood. After implantation or differentiation of ectopic endometrium, further proliferation of the endometriosis implants will depen…

observational 1998
Journal of Endocrinological Investigation ·doi:10.1007/BF03347284

Corticotropin-releasing factor (CRF) is a 41-amino acid neurohormone involved in the neuroendocrine response to stress, also playing a role in cell-mediated immune functions and in inflammation. In the light of recent evidence showing an as…